JOHNSON KENNETH ERLAND
SEC insider (Form 3/4/5 filer). CIK 0001743774. Officer at Xeris Biopharma Holdings, Inc. (XERS). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 31, 2025. Located in CHICAGO, IL.
Companies JOHNSON KENNETH ERLAND has filed insider reports for
- Xeris Biopharma Holdings, Inc. (XERS): Officer, See Remarks
JOHNSON KENNETH ERLAND
CIK: 0001743774
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
XERS
Xeris Biopharma Holdings, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 31, 2025XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect15.5K shares at avg. $3.56$55K - Jan 31, 2025XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect25.8K shares at avg. $3.56$92K - Jan 3, 2025XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect12.4K shares at avg. $3.61$45K
1-3 of 3 transactions